Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03292003 · ClinicalTrials.gov registry record

Journey II Bi-Cruciate Stabilized (BCS) Total Knee System Retrospective Study

A clinical trial of Total Knee Arthroplasty, sponsored by Smith & Nephew.

Completed
Registry status
1,694
Enrollment target
12
Study locations

NCT03292003 is a study of Total Knee Arthroplasty that has completed, run by Smith & Nephew. The registered enrollment target is 1,694 participants, above the 237-participant average among 29 other Total Knee Arthroplasty trials with a reported enrollment target (615% higher). The trial reports 12 study locations across 10 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03292003, a study of Total Knee Arthroplasty, has completed, sponsored by Smith & Nephew.

COMPLETED
Registry status
1,694 participants
Enrollment target
12
Study locations

Study Summary

The objective of this study is to estimate the safety and performance of Journey II BCS TKS.

Conditions Studied

Interventions

  • DEVICE Journey II BCS Total Knee System

Study Locations (12)

Other

  • Jesse Ziekenhuis - Hasselt
  • UZ Leuven Campus - Pellenberg
  • Christen Ortho AG - Bern

Colorado

  • University of Colorado Orthopaedics - Aurora

Florida

  • Andrews Research and Education Foundation - Gulf Breeze

Indiana

  • Methodist Sports Medicine - Indianapolis

New York

  • Hospital for Special Surgery - New York

Pennsylvania

  • University Orthopaedics Center - State College

Tennessee

  • TN Orthopaedic Foundation for Education and Research - Knoxville

Texas

  • San Antonio Orthopaedic Specialists - San Antonio

Trial Details

FieldValue
Enrollment Target 1,694 participants
Start Date 2016-12-30
Est. Completion 2018-09-24

Sponsor

Smith & Nephew

72 total trials

What the Registry Record Tells You About NCT03292003

The ClinicalTrials.gov registry entry for NCT03292003 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,694 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 237-participant average among 29 other Total Knee Arthroplasty trials with a reported enrollment target (615% higher). The listed sponsor is Smith & Nephew, which has 72 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Total Knee Arthroplasty appearing as the primary indexed condition, and to 1 intervention - of which Journey II BCS Total Knee System is the first listed.

NCT03292003 reports 12 study locations spanning 10 distinct geographic areas - top geographies include Other, Colorado, Florida.

Frequently Asked Questions

What is clinical trial NCT03292003 about?

NCT03292003 is a clinical study titled "Journey II Bi-Cruciate Stabilized (BCS) Total Knee System Retrospective Study". The objective of this study is to estimate the safety and performance of Journey II BCS TKS.

What is the current status of trial NCT03292003?

This trial is currently completed. The enrollment target is 1,694 participants. The study started on 2016-12-30. Estimated completion is 2018-09-24.

What conditions does trial NCT03292003 study?

This clinical trial studies the following conditions: Total Knee Arthroplasty.

What interventions are being tested in trial NCT03292003?

The interventions under investigation include: Journey II BCS Total Knee System (DEVICE).

Who is sponsoring clinical trial NCT03292003?

This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03292003 being conducted?

This trial has 12 study locations across Colorado, Florida, Indiana, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Total Knee Arthroplasty

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.